Armstrong AJ, et al. Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial. ASCO-GU 2019, abstract 29.
Update KEYNOTE-716: aanhoudend voordeel pembrolizumab bij melanoom
mrt 2024 | Dermato-oncologie